Skip links

Pillars of Success for 505(b)(2) Drug Development

Date: Thursday, April 26, 2023

Speaker: William Salminen, PhD, DABT, PMP, Vice President, Nonclinical Safety and Toxicology

This presentation is part of a series of webinars on 505(b)(2) NDA drug development that highlights the diversity, simplicity, and complexity of the 505(b)(2) application process. This session focuses on the five pillars for successful 505(b)(2) product development: science, regulatory, medical, commercial and legal/IP/business.

View the other webinars in the series here:

View the Webinar